San Sebastian, Gipuzkoa, Spain, December 4, 2024 - VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from ...
lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners ("Ampersand"), a private equity firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback